Wyld Networks corrects warrant proceeds estimate to SEK 16.5 million from SEK 4.5 million
Bitget2026/10/08 12:45Wyld Networks issued a correction to its Oct. 6, 2026 financing announcement on convertibles and warrants. Potential proceeds from full warrant exercise revised to about SEK 16.5 million from SEK 4.5 million. SEK 4.5 million refers to the maximum share-capital increase from warrant exercise, not cash proceeds. All other terms in the earlier announcement remain unchanged. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wyld Networks AB published the original content used to generate this news brief via Cision (Ref. ID: 20261008:BIT:0821:0) on October 08, 2026, and is solely responsible for the information contained therein.
- Wyld Networks issued a correction to its Oct. 6, 2026 financing announcement on convertibles and warrants.
- Potential proceeds from full warrant exercise revised to about SEK 16.5 million from SEK 4.5 million.
- SEK 4.5 million refers to the maximum share-capital increase from warrant exercise, not cash proceeds.
- All other terms in the earlier announcement remain unchanged.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
